MJA THE MEDICAL JOURNAL OF AUSTRALIA S U P P L E M E N T 17 APRIL 2006 VOLUME 184 NUMBER 8 Guidelines for the management of acute coronary syndromes 2006 National Heart Foundation…

1. Clopidogrel (Plavix) By Oksana Ekkert 2. Objectives At the end of this presentation, participants should be able to: Describe CYP2C19 enzyme function and its variant alleles.…

Slide 1 Hemostasis Slide 2 Mechanisms of Hemostasis Hypercoagulability States Bleeding Disorders Slide 3 hemostasis refers to the stoppage of blood flow The normal process…

Slide 1Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLAT elet Inhibition and patient O utcomes trial Outcomes in patients with STEMI…

Slide 1 Slide 2 Antiplatelet Drugs (Anti-thrombotics)Classification 1.Arachidonic acid pathway inhibitors e.g aspirin 2. Phosphodiesterase inhibitors e.g. dipyridamol 3.…

Slide 1 Bleeding and Thrombosis Disorders in the ICU Division of Critical Care Medicine University of Alberta Slide 2 Outline Normal hemostasis Normal hemostasis Coagulation…

Antiplatelets, Anticoagulant, Antithrombotic/Fibrinolytic Dr. dr. Nicolaski Lumbuun, SpFK Faculty of Medicine Universitas Pelita Harapan Learning Objectives To describe the…

Clopidogrel Audit Vikas Jasoria December 2006 What is it? Clopidogrel is a thienopyridine antiplatelet drug which reduces platelet aggregation by inhibiting the binding of…